Human Non-Interferon Macrophage Activating Factor: Biological and Biochemical Characterization

  • John C. Lee
  • Alison M. Badger
  • William J. Johnson
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 239)

Abstract

A HTLV-1 transformed T cell line has been demonstrated to constitutively produce and secrete a lymphokine with macrophage activating properties. This lymphokine was biologically and biochemically distinct from interferon gamma, the interleukins, the colony stimulating factors and lymphotoxin. In vitro treatment of human monocytes with the partially purified lymphokine resulted in the acquisition of microbicidal and tumoricidal activities. The activity was associated with a protein with an apparent molecular weight of 55,000 daltons and an isoelectric point of 5.5. The potential for the efficacy of such a lymphokine in activating macrophages in vivo provides aspirations for its use in the therapy/prevention of opportunistic infections in immunocompromised hosts.

Keywords

Human Monocyte Immunocompromised Host Tumoricidal Activity Constitutive Production Colony Stimulate Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D.O. Adams and T.A. Hamilton, The cell biology of macrophage activation, Ann. Rev. Immunol. 2: 283–318 (1984).CrossRefGoogle Scholar
  2. 2.
    C.F. Nathan, H.W. Murray, M.E. Weibe, and B.Y. Rubin, Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity, J. Exp. Med. 158: 670–689 (1983).PubMedCrossRefGoogle Scholar
  3. 3.
    C.F. Nathan, T.J. Predergast, M.E. Wiebe, E.R. Stanley, E. Platzer, H.G. Remold, K. Welte, B.Y. Rubin, and H.W. Murray, Activation of human macrophages. Comparison of other cytokines with interferon-gamma, J. Exp. Med. 160: 600–605 (1984).PubMedCrossRefGoogle Scholar
  4. 4.
    R.D. Schreiber, Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity, Contemp. Top. Immunobiology 13: 171–198 (1984).Google Scholar
  5. 5.
    J. Le, W. Prensky, Y.K. Yip, Z. Chang, T. Hoffman, H.C. Stevenson, I. Balazs, J.R. Sadlik, and J. Vilcek, Activation of human monocyte cytotoxicity by natural and recombinant immune interferon, J. Immunol. 131: 2821–2826 (1984).Google Scholar
  6. 6.
    R.D. Schreiber, J.L. Pace, S.W. Russell, A. Altman, and D.H. Katz, Macrophage activating factor produced by a T cell hybridoma: physicochemical and biosynthetic resemblance to y-interferon, J. Immunol. 131: 826–832 (1983).PubMedGoogle Scholar
  7. 7.
    J.C. Lee, L. Rebar, P. Young, F.W. Ruscetti, N. Hanna, and G. Poste, Identification and characterization of a human T cell-line derived lymphokine with MAF-like activity distinct from interferon-gamma, J. Immunol. 136: 1322–1328 (1986).PubMedGoogle Scholar
  8. 8.
    J.C. Lee, Constitutive production of a non-interferon macrophage activating factor by HTLV-transformed T cells, Lymphokine Research 5 (S1): S127–5132 (1986).PubMedGoogle Scholar
  9. 9.
    J.C. Lee, A.M. Badger, W.J. Johnson, C.P. Sung, and P. Horan, Human non-gamma interferon macrophage activating factor (MT-2/MAF) elicits multiple and cross-species effects on macrophage activation, Proceedings of the Sixth International Congress of Immunology (1986) (abstract).Google Scholar
  10. 10.
    J.C. Lee, L. Rebar, J. Laydon, B. Dalton, and P.L. Simon, Induction of interleukin-1 as an indicator for monocyte activation by macrophage activating factor (MT-2/MAF), Lymphokine Research 6: 61 (1987) (abstract).Google Scholar
  11. 11.
    D.L. Hoover, D.S. Finbloom, R.M. Crawford, C.A. Nacy, M. Gilbreath, and M.S. Meltzer, A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro, J. Immunol. 136: 1329–1333 (1986).PubMedGoogle Scholar
  12. 12.
    E.S. Kleinerman, R. Zicht, P.S. Sarin, R.C. Gallo, and I.J. Fidler, Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line, Cancer Res. 44: 4470–4475 (1984).PubMedGoogle Scholar
  13. 13.
    P.W. Andrew, A.D.M. Rees, A. Scoging, N. Dobson, R. Mathews, J.T. Whitthall, A.R.M. Coates, and D.B. Lowrie, Secretion of a macrophage-activating factor distinct from interferon-gamma by human T cell clones, Eur. J. Immunol. 14: 962–964 (1984).PubMedCrossRefGoogle Scholar
  14. 14.
    M.S. Meltzer, M. Gilbreath, C.A. Nacy, and R.D. Schreiber, Macrophage activation factor from EL-4 cells distinct from murine gamma interferon (IFN), Fed. Proc. 44: 1697 (1985) (abstract).Google Scholar
  15. 15.
    Y. Buchmuller, W.Y. Weiser, and H.G. Remold, Partial purification and characterization of a human lymphokine which induces anti-leishmanial activity in mouse macrophages, Cell. Immun. 90: 242–250 (1985).Google Scholar
  16. 16.
    C.M. Jones, C.A. Prince, M.P. Langford, and J.P. Hester, Identification of a human monocyte cytotoxicity-inducing factor from T cell hybridomas produced from Sezary cells, J. Immunol. 137: 571–577 (1986).PubMedGoogle Scholar
  17. 17.
    S. Gregory, R.S. Kornbluth, H. Helin, H.G. Remold, and T.S. Edgington, Monocyte procoagulant inducing factor: A lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen, J. Immunol. 137: 3231–3239 (1986).PubMedGoogle Scholar
  18. 18.
    S. Hinuma, K. Sugamura, K. Tsukamoto, and Y. Hinuma, Constitutive production of phagocytosis inducing factor(s) in a monocyte/macrophage lineage cell line (THP-1) by retrovirus-transformed human T cell lines, Microbiol. Immunol. 28: 935–947 (1984).Google Scholar
  19. 19.
    J.B. Margolick, J.L. Ambrus, Jr., D.J. Volkman, and A.S. Fauci, Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-cc and interferon-y, J. Immunol. 136: 546–554 (1986).Google Scholar
  20. 20.
    K.H. Grabstein, D.L. Urdal, R.J. Tushinshi, D.Y. Mochizuki, V.L. Price, M.A. Cantrell, S. Gillis, and P.J. Conlon, Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor, Science 232–506 (1986).Google Scholar
  21. 21.
    M.K. Warren, and P. Ralph, Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity, J. Immunol. 137: 2281–2285 (1986).PubMedGoogle Scholar
  22. 22.
    R.M. Crawford, D.S. Finbloom, J. Ohara, W.E. Paul, and M.S. Meltzer, B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens, J. Immunol. 139: 135–141 (1987).PubMedGoogle Scholar
  23. 23.
    S.A. Salahuddin, P.D. Markham, S.G. Lindner, J. Gotenberg, M. Popovic, H. Hemmit, P.S. Sarin, and R.C. Gallo, Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I, Science 223: 703–707 (1984).PubMedCrossRefGoogle Scholar
  24. 24.
    I. Myoshi, I. Kuibonishi, S. Yoshimoto, R. Akagi, Y. Ohtsuki, Y. Shiraishi, K. Nagata and Y. Hinuma, Type C virus particles in an end T cell line derived by co-cultivating normal human cord leukocytes and human leukemia cells, Nature 294: 770–771 (1981).CrossRefGoogle Scholar
  25. 25.
    E. Pick, and D. Mizel, Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader, J. Immunol. Methods 46: 211–226 (1981).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • John C. Lee
    • 1
  • Alison M. Badger
    • 1
  • William J. Johnson
    • 1
  1. 1.Department of Immunology & Antiinfectives TherapySmith Kline & French LaboratoriesPhiladelphiaUSA

Personalised recommendations